With 2.71 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.18 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $115.73 whereas the lowest price it dropped to was $107.76. The 52-week range on HQY shows that it touched its highest point at $115.59 and its lowest point at $65.01 during that stretch. It currently has a 1-year price target of $119.93. Beta for the stock currently stands at 0.49.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HQY was up-trending over the past week, with a rise of 11.41%, but this was up by 23.67% over a month. Three-month performance surged to 9.05% while six-month performance rose 11.35%. The stock gained 38.42% in the past year, while it has gained 17.83% so far this year. A look at the trailing 12-month EPS for HQY yields 1.37 with Next year EPS estimates of 4.41. For the next quarter, that number is 0.92. This implies an EPS growth rate of 18.59% for this year and 19.14% for next year. EPS is expected to grow by 19.03% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 13.44%.
Float and Shares Shorts:
At present, 86.71 million HQY shares are outstanding with a float of 84.20 million shares on hand for trading. On 2025-05-15, short shares totaled 5.82 million, which was 672.0 higher than short shares on 1744675200. In addition to Mr. Scott R. Cutler J.D. as the firm’s CEO, President & Director, Dr. Stephen D. Neeleman M.D. serves as its Founder & Vice Chairman.
Institutional Ownership:
Through their ownership of 1.08824 of HQY’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-01-31, HQY reported revenue of $330844000.0 and operating income of $84353000.0. The EBITDA in the recently reported quarter was $nan and diluted EPS was $nan.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HQY since 11 analysts follow the stock currently. There are 10 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With HQY analysts setting a high price target of 130.0 and a low target of 104.0, the average target price over the next 12 months is 119.92857. Based on these targets, HQY could surge 14.98% to reach the target high and fall by -8.01% to reach the target low. Reaching the average price target will result in a growth of 6.08% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $2.24679 being high and $2.12643 being low. For HQY, this leads to a yearly average estimate of $2.19664. Based on analyst estimates, the high estimate for the next quarter is $0.97 and the low estimate is $0.86. The average estimate for the next quarter is thus $0.91.
